Federated Hermes Inc. Has $22.04 Million Holdings in Humana Inc. (NYSE:HUM)

Key Points

• Federated Hermes Inc. increased its stake in Humana Inc. by 6.3% during the first quarter, holding a total of 83,276 shares valued at approximately $22.04 million.
• Several institutional investors, including American Century Companies Inc. and Summit Financial LLC, have also boosted their stakes in Humana, indicating growing investor interest.
• Humana's recent earnings report revealed a net margin of 1.28% and revenue growth of 9.6% year-over-year, though EPS fell short of analysts' expectations.

Federated Hermes Inc. increased its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 6.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 83,276 shares of the insurance provider's stock after buying an additional 4,919 shares during the quarter. Federated Hermes Inc. owned 0.07% of Humana worth $22,035,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of HUM. Revolve Wealth Partners LLC bought a new stake in Humana during the fourth quarter worth about $202,000. American Century Companies Inc. boosted its holdings in shares of Humana by 8.8% in the 4th quarter. American Century Companies Inc. now owns 12,655 shares of the insurance provider's stock worth $3,211,000 after acquiring an additional 1,027 shares in the last quarter. Orion Portfolio Solutions LLC grew its position in Humana by 3.7% during the 4th quarter. Orion Portfolio Solutions LLC now owns 4,834 shares of the insurance provider's stock worth $1,226,000 after acquiring an additional 171 shares during the last quarter. Summit Financial LLC increased its holdings in Humana by 19.2% during the 4th quarter. Summit Financial LLC now owns 1,409 shares of the insurance provider's stock valued at $359,000 after purchasing an additional 227 shares in the last quarter. Finally, HighPoint Advisor Group LLC raised its position in Humana by 6.1% in the 4th quarter. HighPoint Advisor Group LLC now owns 1,509 shares of the insurance provider's stock valued at $388,000 after purchasing an additional 87 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Price Performance

Shares of HUM stock opened at $249.65 on Friday. The firm has a market capitalization of $30.13 billion, a price-to-earnings ratio of 19.16, a price-to-earnings-growth ratio of 1.72 and a beta of 0.44. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $382.72. The company has a quick ratio of 1.91, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a fifty day moving average of $234.64 and a 200-day moving average of $255.48.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. During the same period in the previous year, the firm posted $6.96 earnings per share. The firm's revenue was up 9.6% on a year-over-year basis. On average, equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on HUM shares. Oppenheimer increased their target price on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, May 1st. Barclays set a $275.00 price objective on shares of Humana and gave the company an "equal weight" rating in a research report on Thursday. Piper Sandler reduced their target price on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday. Bank of America dropped their price objective on shares of Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a research report on Tuesday, June 17th. Finally, Wells Fargo & Company set a $348.00 price objective on Humana in a report on Friday, July 18th. Sixteen research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $281.62.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.